Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.Weijian Guo, Xiaofeng Wang, Li‐Xin Qiu et al.|Journal of Clinical Oncology|2021Cited by 2